Annotate, Filter and Report CNVs with InHelix | GenomeWeb
July 12, 2016
Sponsored by
Diploid

Annotate, Filter and Report CNVs with InHelix

Partner Webinar

Dr. Peter Schols is the founder and CEO of Diploid, a company dedicated to providing world class solutions for rare disease diagnostics.

InHelix is software for annotating, visualizing and reporting CNVs obtained from NGS, with a focus on rare disease diagnostics. With its unique features such as live filtering, intelligent CNV prioritization and integration of phenotype data, InHelix provides a new, efficient and user-friendly solution for CNV analysis.

 

Sponsored by

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.